Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Haemonetics (HAE) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for Haemonetics (HAE) over the last 17 years, with Q4 2025 value amounting to $2.0 million.

  • Haemonetics' Cash from Financing Activities rose 4731.88% to $2.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$228.4 million, marking a year-over-year decrease of 21608.26%. This contributed to the annual value of $108.8 million for FY2025, which is 18518.49% up from last year.
  • Haemonetics' Cash from Financing Activities amounted to $2.0 million in Q4 2025, which was up 4731.88% from -$76.6 million recorded in Q3 2025.
  • In the past 5 years, Haemonetics' Cash from Financing Activities registered a high of $432.8 million during Q2 2021, and its lowest value of -$151.4 million during Q1 2025.
  • Over the past 5 years, Haemonetics' median Cash from Financing Activities value was -$2.9 million (recorded in 2021), while the average stood at $19.3 million.
  • Data for Haemonetics' Cash from Financing Activities shows a peak YoY increase of 5590133.78% (in 2024) and a maximum YoY decrease of 386144.73% (in 2024) over the last 5 years.
  • Haemonetics' Cash from Financing Activities (Quarter) stood at -$3.3 million in 2021, then crashed by 1398.64% to -$49.7 million in 2022, then soared by 320.27% to $109.4 million in 2023, then crashed by 98.74% to $1.4 million in 2024, then soared by 47.32% to $2.0 million in 2025.
  • Its Cash from Financing Activities stands at $2.0 million for Q4 2025, versus -$76.6 million for Q3 2025 and -$2.4 million for Q2 2025.